![](/img/cover-not-exists.png)
PDB63 THE UTILIZATION OF ROSIGLITAZONE AND PIOGLITAZONE AFTER THE CARDIOVASCULAR RISK-WARNINGS: WAS THERE A DIFFERENTIAL EFFECT?
R Jain, CD Mullins, H Lee, W WongVolume:
12
Year:
2009
Language:
english
DOI:
10.1016/s1098-3015(10)75041-5
File:
PDF, 70 KB
english, 2009